Dogan Onugoren M, Golombeck KS, Bien C, Abu-Tair M, Brand M, Bulla-Hellwig M et al (2016) Immunoadsorption therapy in autoimmune encephalitides. Neurol Neuroimmunol Neuroinflamm 3(2):e207

Article  PubMed  PubMed Central  Google Scholar 

Spatola M, Dalmau J (2017) Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis. Curr Opin Neurol 30(3):345–353

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCracken L, Zhang J, Greene M, Crivaro A, Gonzalez J, Kamoun M, Lancaster E (2017) Improving the antibody-based evaluation of autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 4(6):e404

Article  PubMed  PubMed Central  Google Scholar 

Zrzavy T, Höftberger R, Wimmer I, Berger T, Rommer P, Macher S (2021) Longitudinal CSF findings in autoimmune encephalitis—A. Monocentric Cohort Study 12

Dürr M, Nissen G, Sühs K-W, Schwenkenbecher P, Geis C, Ringelstein M et al (2021) CSF findings in acute NMDAR and LGI1 antibody–associated autoimmune encephalitis. 8(6):e1086

Hiew FL, Thit WM, Alexander M, Thirugnanam U, Siritho S, Tan K et al (2021) Consensus recommendation on the use of therapeutic plasma exchange for adult neurological diseases in Southeast Asia from the Southeast Asia therapeutic plasma exchange consortium. J Cent Nerv Syst Dis 13:11795735211057314

Article  PubMed  PubMed Central  Google Scholar 

McKeon A (2016) Autoimmune encephalopathies and Dementias. Continuum (Minneap Minn) 22(2 Dementia):538–558

PubMed  Google Scholar 

Dalmau J, Graus F, Antibody-Mediated, Encephalitis (2018) N Engl J Med 378(9):840–851

Article  PubMed  Google Scholar 

Smets I, Titulaer MJ (2022) Antibody therapies in Autoimmune Encephalitis. Neurotherapeutics 19(3):823–831

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watanabe K, Ohashi S, Watanabe T, Kakinuma Y, Kinno R (2024) Case report: recovery from refractory myasthenic crisis to minimal symptom expression after add-on treatment with efgartigimod. Front Neurol 15:1321058

Article  PubMed  PubMed Central  Google Scholar 

Zhu LN, Hou HM, Wang S, Zhang S, Wang GG, Guo ZY, Wu J (2023) FcRn inhibitors: a novel option for the treatment of myasthenia gravis. Neural Regen Res 18(8):1637–1644

CAS  PubMed  PubMed Central  Google Scholar 

Vanoli F, Mantegazza R (2023) Current drug treatment of myasthenia gravis. Curr Opin Neurol 36(5):410–415

Article  PubMed  Google Scholar 

Ulrichts P, Guglietta A, Dreier T, van Bragt T, Hanssens V, Hofman E et al (2018) Neonatal fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans 128:4372–4386

Peter HH, Ochs HD, Cunningham-Rundles C, Vinh DC, Kiessling P, Greve B, Jolles S (2020) Targeting FcRn for immunomodulation: benefits, risks, and practical considerations. J Allergy Clin Immunol 146(3):479–91e5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ulrichts P, Guglietta A, Dreier T, van Bragt T, Hanssens V, Hofman E et al (2018) Neonatal fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans. J Clin Invest 128(10):4372–4386

Article  PubMed  PubMed Central  Google Scholar 

Stathopoulos P, Dalakas MC (2022) Evolution of Anti-B cell therapeutics in Autoimmune Neurological diseases. Neurotherapeutics 19(3):691–710

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Stefano V, Alonge P, Rini N, Militello M, Lupica A, Torrente A, Brighina F (2023) Efgartigimod beyond myasthenia gravis: the role of FcRn-targeting therapies in stiff-person syndrome. J Neurol

Qiao S, Zhang SC, Wang ZH, Wang L, Zhang RR, Li HY et al (2022) Coexistence of multiple anti-neuronal antibodies in autoimmune encephalitis in China: a multi-center study. Front Immunol 13:858766

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kammeyer R, Piquet AL (2019) Multiple co-existing antibodies in autoimmune encephalitis: a case and review of the literature. J Neuroimmunol 337:577084

Article  CAS  PubMed  Google Scholar 

Xie Y, Wen J, Zhao Z, Liu H, Xie N (2021) Autoimmune encephalitis with coexistent LGI1 and GABA(B)R1 antibodies: case report. BMC Neurol 21(1):461

Article  PubMed  PubMed Central  Google Scholar 

Schiff P, Muniz-Castrillo S, Do LD, Fantini ML, Chanson E, Rogemond V et al (2023) Anti-LGI1 encephalitis with co-occurring IgLON5 antibodies: clinical features and human leukocyte Antigen haplotypes. Neurol Neuroimmunol Neuroinflamm 10(4)

Abbatemarco JR, Yan C, Kunchok A, Rae-Grant A (2021) Antibody-mediated autoimmune encephalitis: a practical approach 88(8):459–471

Banerjee A, Larsen RS, Philpot BD, Paulsen O (2016) Roles of presynaptic NMDA receptors in Neurotransmission and plasticity. Trends Neurosci 39(1):26–39

Article  CAS  PubMed  Google Scholar 

Lovero KL, Fukata Y, Granger AJ, Fukata M, Nicoll RA (2015) The LGI1-ADAM22 protein complex directs synapse maturation through regulation of PSD-95 function. Proc Natl Acad Sci U S A 112(30):E4129–E4137

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bastiaansen AEM, van Steenhoven RW, de Bruijn M, Crijnen YS, van Sonderen A, van Coevorden-Hameete MH et al (2021) Autoimmune encephalitis resembling dementia syndromes. Neurol Neuroimmunol Neuroinflamm 8(5)

Sandweiss AJ, Kannan V, Desai NK, Kralik SF, Muscal E, Fisher KS (2023) Arterial spin labeling changes parallel asymmetric perisylvian and perirolandic symptoms in 3 Pediatric cases of Anti-NMDAR Encephalitis. Neurol Neuroimmunol Neuroinflamm 10(4)

Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K et al (2018) The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain 141(2):348–356

Article  PubMed  Google Scholar 

Gao L, Liu A, Zhan S, Wang L, Li L, Guan L et al (2016) Clinical characterization of autoimmune LGI1 antibody limbic encephalitis. Epilepsy Behav 56:165–169

Article  PubMed  Google Scholar 

Van Sonderen A, Ariño H, Petit-Pedrol M, Leypoldt F, Körtvélyessy P, Wandinger KP et al (2016) The clinical spectrum of Caspr2 antibody-associated disease. Neurology 87(5):521–528

Article  PubMed  PubMed Central  Google Scholar 

Bataller L, Galiano R, García-Escrig M, Martínez B, Sevilla T, Blasco R et al (2010) Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology 74(3):265–267

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ji T, Huang Z, Lian Y, Wang C, Zhang Q, Li J (2020) A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies. BMC Neurol 20(1):336

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang XJWM, Yu L, Peng T, Hu WT, Sun GF et al (2020) Clinical analysis of autoimmune encephalitis with multiple anti-neuronal antibodies. Chin J Practical Nerv Dis Chin J Practical Nerv Dis. 23(6)

Liu XYCZ, Wu GL, Peng T (2022) A case of autoimmune encephalitis with positive for anti-LGI1 and anti-N-methyl-D-aspartate receptor antibodies. Natl Med J China (001):048

Tuohy VK, Kinkel RP (2000) Epitope spreading: a mechanism for progression of autoimmune disease. Arch Immunol Ther Exp (Warsz) 48(5):347–351

CAS  PubMed  Google Scholar 

HC. Q (2018) Multi-anti-neuronal antibody-positive autoimmune encephalitis:2 case reports and review of literature. Guangxi Medical University, Guangxi

Google Scholar 

Qiao S, Zhang S-C, Wang Z-H, Wang L, Zhang R-R, Li H-Y et al (2022) Coexistence of multiple anti-neuronal antibodies in autoimmune encephalitis in China: a multi-center study. Front Immunol 13

Ren HTYX, Guang HZ, Gao XY, Peng B, Zhu YC et al (2016) Clinical analysis of autoimmune encephalitis with co-existence of multiple anti-neuronal antibodies. Chin J Neurol 49(1):21–25

Google Scholar 

Qiu ZDLZ, Li DW, Song XD, Wang JS, Dong HQ (2020) Clinical analysis of paraneoplastic neurological syndrome with co-existence of multiple anti-neuronal antibodies. Chin J Neuroimmunol Neurol 27(4):5

Google Scholar 

Zhou Y, Chen H, Zhu M, Li M, Wang L, Xie Z et al (2024) Clinical characteristics of autoimmune encephalitis with co-existence of multiple anti-neuronal antibodies. BMC Neurol 24(1):1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yeo T, Chen Z, Yong KP, Wong PYW, Chai JYH, Tan K (2018) Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies. J Neurol Sci 391:64–71

Article  CAS  PubMed  Google Scholar 

Gadoth A, Nisnboym M, Alcalay Y, Zubkov A, Schwartz I, Schwartz D et al (2023) Electrolyte imbalance in anti-LGI1 Encephalitis: it is not all in your head. Neurol Neuroimmunol Neuroinflamm 10(6)

Muhr P, Goldammer U, Bien CG, Bien C, Sindern E (2018) [Severe hyponatremia as precursor of LGI1 autoimmune encephalitis]. Nervenarzt 89(8):942–944

Article  CAS  PubMed  Google Scholar